Skip to content

Evaluating Color Perception Under LED Red/Green and Green Dominant Light

Evaluating Color Perception Under LED Red/Green and Green Dominant Light

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01927536
Enrollment
39
Registered
2013-08-22
Start date
2013-04-23
Completion date
2019-01-10
Last updated
2019-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Color Blindness, Acquired

Brief summary

The investigators are testing a Light-emitting Diode (LED) flashlight from First-Light™ USA called the Tomahawk MC Tactical Light to determine the range of colors people are able to see with these flashlights at night. The flashlight has been designed to reduce visibility of the user and uses a combination of green and red LED lamps to achieve this. In this study investigators wish to determine how well a subject can differentiate colors at night in a quantifiable manner. Investigators will use the Farnsworth Munsell 100 hue test which requires the user to put shades of red, green, blue and yellow into progressive color order which is scored according to the manufactures specifications.

Interventions

DEVICEWhite LED Flashlight

white light setting

DEVICERed/Green Green Dominant LED Flashlight

Green LED light dominant setting

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 66 Years
Healthy volunteers
Yes

Inclusion criteria

* normal vision * 18-65 years

Exclusion criteria

* blindness * colorblind * pregnant women * prisoners * decisionally challenged

Design outcomes

Primary

MeasureTime frameDescription
Change in Normal Color vision1 hrThe Farnsworth Munsell 100 Hue Test is used to determine normal color vision and vision using the red green Tomahawk LED flashlight.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026